Champions Oncology - Champions' partnership with GigaMune will combine our novel Autologous Tumor Infiltrating Lymphocyte (TIL) platform with Gigamune's T Cell Receptor (TCR) Discovery platform to accelerate next gen therapies & diagnostics.
About Us
Champions Oncology Webinar Channel - BrightTALK
Champions Oncology - CJ Yu is a Senior Scientist at Champions Oncology. His role involves analyzing biomarkers within patient cancer tissues. He is passionate about integrating new technologies in his research. Learn
Champions Oncology - Crunchbase Company Profile & Funding
CHAMPIONS ONCOLOGY, INC. : CSBR Stock Price | US15870P3073 | MarketScreener
Champions Oncology, Inc. $CSBR Q2 2023 Earnings Call - YouTube
Champions Oncology, Inc.
Champions Oncology (ChampsOnco) - Profile | Pinterest
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology Company Profile: Stock Performance & Earnings | PitchBook
Champions Oncology - Wikipedia
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology - FREE WEBINAR: Champions Oncology invites you to register for our new webinar, PPMO™: Disrupting Biomarker & Target Discovery using AI computational modeling on April 27th at 12pm EST. https://hubs.li/Q018h8zg0 #
Publications
Case Study: Champions TumorGraft® Guides the Development of a Novel, Selective Dual BRAF/EGFR Inhibitor, CEP-32496
Champions Oncology Second Quarter 2023 Earnings: US$0.001 loss per share (vs US$0.021 profit in 2Q 2022)
ChampionsOncology (@ChampionsOncol1) / Twitter
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
Champions Oncology (CSBR) - 6 Price Charts 2007-2022 (History)
Champions Oncology Reports Quarterly Revenue of $8.8 Million
Champions Oncology Announces its Lumin Bioinformatics Platform Selected as a Finalist for the 'Best in Show' Competition at Bio-IT World Conference & Expo
Champions Oncology and BGI Americas Announce a Strategic Partnership to provide Mass Spectrometry Proteomics, Metabolomics, and multi-omic Data Analysis Solutions
Champions Oncology | Public Marketplace
Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 13, 2022
ChampionsOncology (@ChampionsOncol1) / Twitter
